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isolates tested under planktonic conditions, with the exception of C. parapsilosis and C. 165 krusei. Interestingly, AXD also displayed striking activity against clinically relevant In case of filamentous fungi, low AXD MIC50 values of 1.5-3 μg/ml was observed for 171 all filamentous fungi (Mucorales and Aspergillus spp., plates read at 48 h), including the 172 molds L. corymbifera and S. apiospermum (read at 72 h) that have poor outcome with 173 current clinically available antifungal drugs (22). Inhibition of planktonic growth by AXD, 174 monitored microscopically, revealed a complete inhibition of filamentation or 175 proliferation of the imaged fungi (Fig 1B) . Of particular importance was the finding that 176 AXD was able to decimate at low concentrations (1.5-6 μg/ml), mature biofilms of 177 Candida, Cryptococcus and Aspergillus spp. that are known to be resistant to almost all 178 classes of antifungal drugs ( Table 2 , also see S2 for AXD activity on Candida spp.). In 179 fact, at 10 fold lower concentrations (150 ng/ml) of planktonic MICs', AXD could inhibit 180 lateral yeast formation and biofilm dispersal in C. albicans (Fig 1C) . Dispersal of lateral 181 yeast cells from a biofilm biomass is the link between contaminated catheters and 182 disseminated candidiasis (8, 23) . Inhibition of dispersal with just nano-molar levels of 183 AXD can help seal the biofilm reservoir and curtail further proliferation and robustness 184 of a biofilm.
185
Alexidine dihydrochloride is a bis(biguanide) in which the common 2-ethylhexyl chain 186 has been attached to each biguanide unit and the two units are linked by a 1,6-hexanediamine chain (S3A). This compound initially identified for its anti-bacterial 188 properties, is also found as an inducer of mitochondrial dysfunction and apoptosis (11, 189 24). AXD has been proposed in several studies as an anti-plaque agent, mouthwash, 190 and with potential to be used in endodontic treatment to eliminate biofilms (19, 20, 25) .
191
These reports, along with our present findings, serve as precedents for the development Considering that AXD displayed enhanced efficacy against fungal organisms, we 203 evaluated the extent of its cell toxicity (CC50) to mammalian cells. Results showed that 204 AXD resulted in 50% killing of HUVECs and lung epithelial cells, at concentrations 5-10 205 fold higher than the MIC required to kill planktonically growing fungal pathogens (CC50 206 >7.37 μg/ml vs planktonic MIC50 of 0.73-1.5 μg/ml) ( Fig. 2A, B) . Previous studies have 207 reported similar cytotoxicity levels of AXD against various other cell lines (19, 27, 28) . 208 We further tested the toxicity of AXD to a human bone-marrow derived macrophage cell 209 line to understand its effect on the immune cells. AXD displayed a slightly higher toxicity tested, and the catheter is filled with heparin lock solution and plug-sealed. Following 
